These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|||||||
(State or other jurisdiction
of incorporation or organization) |
(I.R.S. Employer Identification No.) | |||||||
|
||||||||
|
|
|||||||
(Address of principal executive offices) | (Zip Code) |
Title of each class
|
Trading symbol(s) |
Name of each exchange on which registered
|
||||||
|
|
|
||||||
|
|
|
||||||
|
|
|
||||||
|
|
|
||||||
|
|
|
||||||
|
|
|
||||||
|
|
|
||||||
|
|
|
||||||
|
|
|
||||||
|
|
|
||||||
|
|
|
|
☒ | Accelerated filer | ☐ | |||||||||||||||||
Non-accelerated filer | ☐ | Smaller reporting company |
|
|||||||||||||||||
Emerging growth company |
|
Page | ||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
March 26,
2022 |
March 27,
2021 |
||||||||||||||||||||
Net sales: | |||||||||||||||||||||||
Products | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Services |
|
|
|
|
|||||||||||||||||||
Total net sales |
|
|
|
|
|||||||||||||||||||
Cost of sales: | |||||||||||||||||||||||
Products |
|
|
|
|
|||||||||||||||||||
Services |
|
|
|
|
|||||||||||||||||||
Total cost of sales |
|
|
|
|
|||||||||||||||||||
Gross margin |
|
|
|
|
|||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Research and development |
|
|
|
|
|||||||||||||||||||
Selling, general and administrative |
|
|
|
|
|||||||||||||||||||
Total operating expenses |
|
|
|
|
|||||||||||||||||||
Operating income |
|
|
|
|
|||||||||||||||||||
Other income/(expense), net |
|
|
(
|
|
|||||||||||||||||||
Income before provision for income taxes |
|
|
|
|
|||||||||||||||||||
Provision for income taxes |
|
|
|
|
|||||||||||||||||||
Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Earnings per share: | |||||||||||||||||||||||
Basic | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Diluted | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Shares used in computing earnings per share: | |||||||||||||||||||||||
Basic |
|
|
|
|
|||||||||||||||||||
Diluted |
|
|
|
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
March 26,
2022 |
March 27,
2021 |
||||||||||||||||||||
Net income
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Other comprehensive income/(loss): | |||||||||||||||||||||||
Change in foreign currency translation, net of tax
|
(
|
(
|
(
|
|
|||||||||||||||||||
Change in unrealized gains/losses on derivative instruments, net of tax:
|
|||||||||||||||||||||||
Change in fair value of derivative instruments |
|
|
|
|
|||||||||||||||||||
Adjustment for net (gains)/losses realized and included in net income
|
(
|
|
(
|
|
|||||||||||||||||||
Total change in unrealized gains/losses on derivative instruments
|
|
|
|
|
|||||||||||||||||||
Change in unrealized gains/losses on marketable debt securities, net of tax:
|
|||||||||||||||||||||||
Change in fair value of marketable debt securities
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
Adjustment for net (gains)/losses realized and included in net income
|
|
(
|
|
(
|
|||||||||||||||||||
Total change in unrealized gains/losses on marketable debt securities
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
Total other comprehensive income/(loss) |
(
|
(
|
(
|
|
|||||||||||||||||||
Total comprehensive income | $ |
|
$ |
|
$ |
|
$ |
|
March 26,
2022 |
September 25,
2021 |
||||||||||
ASSETS: | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||
Marketable securities |
|
|
|||||||||
Accounts receivable, net |
|
|
|||||||||
Inventories |
|
|
|||||||||
Vendor non-trade receivables |
|
|
|||||||||
Other current assets |
|
|
|||||||||
Total current assets |
|
|
|||||||||
Non-current assets: | |||||||||||
Marketable securities |
|
|
|||||||||
Property, plant and equipment, net |
|
|
|||||||||
Other non-current assets |
|
|
|||||||||
Total non-current assets
|
|
|
|||||||||
Total assets
|
$ |
|
$ |
|
|||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY: | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ |
|
$ |
|
|||||||
Other current liabilities |
|
|
|||||||||
Deferred revenue |
|
|
|||||||||
Commercial paper |
|
|
|||||||||
Term debt |
|
|
|||||||||
Total current liabilities |
|
|
|||||||||
Non-current liabilities:
|
|||||||||||
Term debt
|
|
|
|||||||||
Other non-current liabilities
|
|
|
|||||||||
Total non-current liabilities
|
|
|
|||||||||
Total liabilities
|
|
|
|||||||||
Commitments and contingencies |
|
|
|||||||||
Shareholders’ equity: | |||||||||||
Common stock and additional paid-in capital, $
|
|
|
|||||||||
Retained earnings |
|
|
|||||||||
Accumulated other comprehensive income/(loss) |
(
|
|
|||||||||
Total shareholders’ equity |
|
|
|||||||||
Total liabilities and shareholders’ equity | $ |
|
$ |
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
March 26,
2022 |
March 27,
2021 |
||||||||||||||||||||
Total shareholders’ equity, beginning balances | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Common stock and additional paid-in capital: | |||||||||||||||||||||||
Beginning balances |
|
|
|
|
|||||||||||||||||||
Common stock issued
|
|
|
|
|
|||||||||||||||||||
Common stock withheld related to net share settlement of equity awards
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
Share-based compensation |
|
|
|
|
|||||||||||||||||||
Ending balances |
|
|
|
|
|||||||||||||||||||
Retained earnings: | |||||||||||||||||||||||
Beginning balances |
|
|
|
|
|||||||||||||||||||
Net income |
|
|
|
|
|||||||||||||||||||
Dividends and dividend equivalents declared |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Common stock withheld related to net share settlement of equity awards
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
Common stock repurchased |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Ending balances |
|
|
|
|
|||||||||||||||||||
Accumulated other comprehensive income/(loss): | |||||||||||||||||||||||
Beginning balances |
(
|
|
|
(
|
|||||||||||||||||||
Other comprehensive income/(loss) |
(
|
(
|
(
|
|
|||||||||||||||||||
Ending balances |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Total shareholders’ equity, ending balances | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Dividends and dividend equivalents declared per share or RSU | $ |
|
$ |
|
$ |
|
$ |
|
Six Months Ended | |||||||||||
March 26,
2022 |
March 27,
2021 |
||||||||||
Cash, cash equivalents and restricted cash, beginning balances | $ |
|
$ |
|
|||||||
Operating activities: | |||||||||||
Net income |
|
|
|||||||||
Adjustments to reconcile net income to cash generated by operating activities: | |||||||||||
Depreciation and amortization |
|
|
|||||||||
Share-based compensation expense |
|
|
|||||||||
Deferred income tax expense/(benefit) |
|
(
|
|||||||||
Other |
(
|
(
|
|||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable, net |
|
(
|
|||||||||
Inventories |
|
(
|
|||||||||
Vendor non-trade receivables |
|
|
|||||||||
Other current and non-current assets |
(
|
(
|
|||||||||
Accounts payable |
(
|
(
|
|||||||||
Deferred revenue |
|
|
|||||||||
Other current and non-current liabilities |
|
|
|||||||||
Cash generated by operating activities |
|
|
|||||||||
Investing activities: | |||||||||||
Purchases of marketable securities |
(
|
(
|
|||||||||
Proceeds from maturities of marketable securities |
|
|
|||||||||
Proceeds from sales of marketable securities |
|
|
|||||||||
Payments for acquisition of property, plant and equipment |
(
|
(
|
|||||||||
Payments made in connection with business acquisitions, net |
(
|
(
|
|||||||||
Other |
(
|
|
|||||||||
Cash used in investing activities |
(
|
(
|
|||||||||
Financing activities: | |||||||||||
Payments for taxes related to net share settlement of equity awards |
(
|
(
|
|||||||||
Payments for dividends and dividend equivalents |
(
|
(
|
|||||||||
Repurchases of common stock |
(
|
(
|
|||||||||
Proceeds from issuance of term debt, net |
|
|
|||||||||
Repayments of term debt |
(
|
(
|
|||||||||
Proceeds from commercial paper, net |
|
|
|||||||||
Other |
(
|
|
|||||||||
Cash used in financing activities |
(
|
(
|
|||||||||
Increase/(Decrease) in cash, cash equivalents and restricted cash |
(
|
|
|||||||||
Cash, cash equivalents and restricted cash, ending balances | $ |
|
$ |
|
|||||||
Supplemental cash flow disclosure: | |||||||||||
Cash paid for income taxes, net | $ |
|
$ |
|
|||||||
Cash paid for interest | $ |
|
$ |
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
March 26,
2022 |
March 27,
2021 |
||||||||||||||||||||
Numerator: | |||||||||||||||||||||||
Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Denominator: | |||||||||||||||||||||||
Weighted-average basic shares outstanding |
|
|
|
|
|||||||||||||||||||
Effect of dilutive securities |
|
|
|
|
|||||||||||||||||||
Weighted-average diluted shares |
|
|
|
|
|||||||||||||||||||
Basic earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Diluted earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
March 26,
2022 |
March 27,
2021 |
||||||||||||||||||||
iPhone
®
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Mac
®
(1)
|
|
|
|
|
|||||||||||||||||||
iPad
®
(1)
|
|
|
|
|
|||||||||||||||||||
Wearables, Home and Accessories
(1)(2)
|
|
|
|
|
|||||||||||||||||||
Services
(3)
|
|
|
|
|
|||||||||||||||||||
Total net sales
(4)
|
$ |
|
$ |
|
$ |
|
$ |
|
March 26, 2022 | |||||||||||||||||||||||||||||||||||||||||
Adjusted
Cost |
Unrealized
Gains |
Unrealized
Losses |
Fair
Value |
Cash and
Cash Equivalents |
Current
Marketable Securities |
Non-Current
Marketable Securities |
|||||||||||||||||||||||||||||||||||
Cash | $ |
|
$ | — | $ | — | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
Level 1
(1)
:
|
|||||||||||||||||||||||||||||||||||||||||
Money market funds |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Mutual funds |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Subtotal |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Level 2
(2)
:
|
|||||||||||||||||||||||||||||||||||||||||
Equity securities |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
U.S. Treasury securities |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
U.S. agency securities |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Non-U.S. government securities |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Certificates of deposit and time deposits
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Commercial paper |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Corporate debt securities |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Municipal securities |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Mortgage- and asset-backed securities
|
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Subtotal |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Total
(3)
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
September 25, 2021 | |||||||||||||||||||||||||||||||||||||||||
Adjusted
Cost |
Unrealized
Gains |
Unrealized
Losses |
Fair
Value |
Cash and
Cash Equivalents |
Current
Marketable Securities |
Non-Current
Marketable Securities |
|||||||||||||||||||||||||||||||||||
Cash | $ |
|
$ | — | $ | — | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
Level 1
(1)
:
|
|||||||||||||||||||||||||||||||||||||||||
Money market funds |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Mutual funds |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Subtotal |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Level 2
(2)
:
|
|||||||||||||||||||||||||||||||||||||||||
Equity securities |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
U.S. Treasury securities |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
U.S. agency securities |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Non-U.S. government securities |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Certificates of deposit and time deposits
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Commercial paper |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Corporate debt securities |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Municipal securities |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Mortgage- and asset-backed securities
|
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Subtotal |
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Total
(3)
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
Due after 1 year through 5 years | $ |
|
|||
Due after 5 years through 10 years |
|
||||
Due after 10 years |
|
||||
Total fair value | $ |
|
March 26,
2022 |
September 25,
2021 |
||||||||||
Derivative instruments designated as accounting hedges: | |||||||||||
Foreign exchange contracts | $ |
|
$ |
|
|||||||
Interest rate contracts | $ |
|
$ |
|
|||||||
Derivative instruments not designated as accounting hedges: | |||||||||||
Foreign exchange contracts | $ |
|
$ |
|
March 26,
2022 |
September 25,
2021 |
||||||||||
Hedged assets/(liabilities): | |||||||||||
Current and non-current marketable securities | $ |
|
$ |
|
|||||||
Current and non-current term debt | $ |
(
|
$ |
(
|
March 26,
2022 |
September 25,
2021 |
||||||||||
Gross property, plant and equipment | $ |
|
$ |
|
|||||||
Accumulated depreciation and amortization |
(
|
(
|
|||||||||
Total property, plant and equipment, net | $ |
|
$ |
|
March 26,
2022 |
September 25,
2021 |
||||||||||
Long-term taxes payable | $ |
|
$ |
|
|||||||
Other non-current liabilities |
|
|
|||||||||
Total other non-current liabilities | $ |
|
$ |
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
March 26,
2022 |
March 27,
2021 |
||||||||||||||||||||
Interest and dividend income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Other income/(expense), net |
|
|
(
|
|
|||||||||||||||||||
Total other income/(expense), net | $ |
|
$ |
|
$ |
(
|
$ |
|
Six Months Ended | |||||||||||
March 26,
2022 |
March 27,
2021 |
||||||||||
Maturities 90 days or less: | |||||||||||
Proceeds from commercial paper, net | $ |
|
$ |
|
|||||||
Maturities greater than 90 days: | |||||||||||
Proceeds from commercial paper |
|
|
|||||||||
Repayments of commercial paper |
(
|
(
|
|||||||||
Repayments of commercial paper, net |
(
|
(
|
|||||||||
Total proceeds from commercial paper, net | $ |
|
$ |
|
Number of
RSUs
(in thousands)
|
Weighted-Average
Grant Date Fair Value Per RSU |
Aggregate
Fair Value
(in millions)
|
|||||||||||||||
Balance as of September 25, 2021 |
|
$ |
|
||||||||||||||
RSUs granted |
|
$ |
|
||||||||||||||
RSUs vested |
(
|
$ |
|
||||||||||||||
RSUs canceled |
(
|
$ |
|
||||||||||||||
Balance as of March 26, 2022 |
|
$ |
|
$ |
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
March 26,
2022 |
March 27,
2021 |
||||||||||||||||||||
Share-based compensation expense | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Income tax benefit related to share-based compensation expense
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
March 26,
2022 |
March 27,
2021 |
||||||||||||||||||||
Beginning accrued warranty and related costs | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Cost of warranty claims |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Accruals for product warranty |
|
|
|
|
|||||||||||||||||||
Ending accrued warranty and related costs | $ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
March 26,
2022 |
March 27,
2021 |
||||||||||||||||||||
Americas: | |||||||||||||||||||||||
Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Operating income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Europe: | |||||||||||||||||||||||
Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Operating income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Greater China: | |||||||||||||||||||||||
Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Operating income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Japan: | |||||||||||||||||||||||
Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Operating income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Rest of Asia Pacific: | |||||||||||||||||||||||
Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Operating income | $ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
March 26,
2022 |
March 27,
2021 |
||||||||||||||||||||
Segment operating income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Research and development expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Other corporate expenses, net |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Total operating income | $ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
Change |
March 26,
2022 |
March 27,
2021 |
Change | ||||||||||||||||||||||||||||||
Net sales by category: | |||||||||||||||||||||||||||||||||||
iPhone
(1)
|
$ | 50,570 | $ | 47,938 | 5 | % | $ | 122,198 | $ | 113,535 | 8 | % | |||||||||||||||||||||||
Mac
(1)
|
10,435 | 9,102 | 15 | % | 21,287 | 17,777 | 20 | % | |||||||||||||||||||||||||||
iPad
(1)
|
7,646 | 7,807 | (2) | % | 14,894 | 16,242 | (8) | % | |||||||||||||||||||||||||||
Wearables, Home and Accessories
(1)(2)
|
8,806 | 7,836 | 12 | % | 23,507 | 20,807 | 13 | % | |||||||||||||||||||||||||||
Services
(3)
|
19,821 | 16,901 | 17 | % | 39,337 | 32,662 | 20 | % | |||||||||||||||||||||||||||
Total net sales | $ | 97,278 | $ | 89,584 | 9 | % | $ | 221,223 | $ | 201,023 | 10 | % |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
Change |
March 26,
2022 |
March 27,
2021 |
Change | ||||||||||||||||||||||||||||||
Net sales by reportable segment: | |||||||||||||||||||||||||||||||||||
Americas | $ | 40,882 | $ | 34,306 | 19 | % | $ | 92,378 | $ | 80,616 | 15 | % | |||||||||||||||||||||||
Europe | 23,287 | 22,264 | 5 | % | 53,036 | 49,570 | 7 | % | |||||||||||||||||||||||||||
Greater China | 18,343 | 17,728 | 3 | % | 44,126 | 39,041 | 13 | % | |||||||||||||||||||||||||||
Japan | 7,724 | 7,742 | — | % | 14,831 | 16,027 | (7) | % | |||||||||||||||||||||||||||
Rest of Asia Pacific | 7,042 | 7,544 | (7) | % | 16,852 | 15,769 | 7 | % | |||||||||||||||||||||||||||
Total net sales | $ | 97,278 | $ | 89,584 | 9 | % | $ | 221,223 | $ | 201,023 | 10 | % |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
March 26,
2022 |
March 27,
2021 |
||||||||||||||||||||
Gross margin: | |||||||||||||||||||||||
Products | $ | 28,167 | $ | 26,236 | $ | 68,287 | $ | 59,784 | |||||||||||||||
Services | 14,392 | 11,843 | 28,515 | 22,623 | |||||||||||||||||||
Total gross margin | $ | 42,559 | $ | 38,079 | $ | 96,802 | $ | 82,407 |
Gross margin percentage: | |||||||||||||||||||||||
Products | 36.4 | % | 36.1 | % | 37.5 | % | 35.5 | % | |||||||||||||||
Services | 72.6 | % | 70.1 | % | 72.5 | % | 69.3 | % | |||||||||||||||
Total gross margin percentage | 43.7 | % | 42.5 | % | 43.8 | % | 41.0 | % |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
March 26,
2022 |
March 27,
2021 |
||||||||||||||||||||
Research and development | $ | 6,387 | $ | 5,262 | $ | 12,693 | $ | 10,425 | |||||||||||||||
Percentage of total net sales | 7 | % | 6 | % | 6 | % | 5 | % | |||||||||||||||
Selling, general and administrative | $ | 6,193 | $ | 5,314 | $ | 12,642 | $ | 10,945 | |||||||||||||||
Percentage of total net sales | 6 | % | 6 | % | 6 | % | 5 | % | |||||||||||||||
Total operating expenses | $ | 12,580 | $ | 10,576 | $ | 25,335 | $ | 21,370 | |||||||||||||||
Percentage of total net sales | 13 | % | 12 | % | 11 | % | 11 | % |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
Change |
March 26,
2022 |
March 27,
2021 |
Change | ||||||||||||||||||||||||||||||
Interest and dividend income | $ | 700 | $ | 718 | $ | 1,350 | $ | 1,465 | |||||||||||||||||||||||||||
Interest expense | (691) | (670) | (1,385) | (1,308) | |||||||||||||||||||||||||||||||
Other income/(expense), net | 151 | 460 | (52) | 396 | |||||||||||||||||||||||||||||||
Total other income/(expense), net | $ | 160 | $ | 508 | (69) | % | $ | (87) | $ | 553 | (116) | % |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
March 26,
2022 |
March 27,
2021 |
March 26,
2022 |
March 27,
2021 |
||||||||||||||||||||
Provision for income taxes | $ | 5,129 | $ | 4,381 | $ | 11,740 | $ | 9,205 | |||||||||||||||
Effective tax rate | 17.0 | % | 15.6 | % | 16.4 | % | 14.9 | % | |||||||||||||||
Statutory federal income tax rate | 21 | % | 21 | % | 21 | % | 21 | % |
Periods |
Total Number
of Shares Purchased |
Average Price
Paid Per Share |
Total Number of Shares
Purchased as Part of Publicly Announced Plans or Programs |
Approximate Dollar Value of
Shares That May Yet Be Purchased
Under the Plans or Programs
(1)
|
||||||||||||||||||||||
December 26, 2021 to January 29, 2022: | ||||||||||||||||||||||||||
November 2021 ASRs | 4,887 |
(2)
|
4,887 | |||||||||||||||||||||||
Open market and privately negotiated purchases
|
43,330 | $ | 170.99 | 43,330 | ||||||||||||||||||||||
January 30, 2022 to February 26, 2022: | ||||||||||||||||||||||||||
Open market and privately negotiated purchases
|
42,895 | $ | 169.71 | 42,895 | ||||||||||||||||||||||
February 27, 2022 to March 26, 2022: | ||||||||||||||||||||||||||
Open market and privately negotiated purchases
|
50,822 | $ | 161.75 | 50,822 | ||||||||||||||||||||||
Total | 141,934 | $ | 17,579 |
Incorporated by Reference | ||||||||||||||||||||||||||
Exhibit
Number
|
Exhibit Description | Form | Exhibit |
Filing Date/
Period End Date |
||||||||||||||||||||||
10.1* | 8-K | 10.1 | 3/4/22 | |||||||||||||||||||||||
10.2* | 8-K | 10.2 | 3/4/22 | |||||||||||||||||||||||
10.3* | 8-K | 10.3 | 3/4/22 | |||||||||||||||||||||||
31.1** | ||||||||||||||||||||||||||
31.2** | ||||||||||||||||||||||||||
32.1*** | ||||||||||||||||||||||||||
101** |
Inline XBRL Document Set for the condensed consolidated financial statements and accompanying notes in Part I, Item 1, “Financial Statements” of this Quarterly Report on Form 10-Q.
|
|||||||||||||||||||||||||
104** |
Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.
|
Date: April 28, 2022
|
Apple Inc. | ||||||||||
By: | /s/ Luca Maestri | ||||||||||
Luca Maestri | |||||||||||
Senior Vice President,
Chief Financial Officer |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|